• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Trice Medical reels in $12M, ex-Embrella founder O’Donnell

Trice Medical reels in $12M, ex-Embrella founder O’Donnell

July 23, 2014 By Brad Perriello

Trice Medical reels in $12M, ex-Embrella founder O'Donnell

Trice Medical said it raised the 1st tranche of an $11.6 million Series B round and named medtech veteran Jeffrey O’Donnell Sr. as its new CEO.

Trice, which is developing a "micro-invasive" device called Mi-eye for outpatient diagnostic arthroscopy, said the round was led by a nearly $1.3 million contribution from Safeguard Scientifics (NYSE:SFE) that’s worth a 9.6% stake. BioStar Ventures and other prior backers also participated, according to a press release.

The 2nd tranche of the round is due when Trice wins 510(k) clearance from the FDA for the Mi-eye device, according to the release, and will see Safeguard drop another nearly $3.8 million for a roughly 26% stake in Trice. Proceeds are slated for commercialization and marketing for the device, Trice said.

"We believe that Trice has the potential to significantly disrupt the current orthopedic diagnostics paradigm," Safeguard managing director for healthcare Dr. Gary Kurtzman said in prepared remarks. "Trice is addressing all 3 major constituents within healthcare – physicians, payers and patients. They already have reimbursement codes for physicians in place; they clearly deliver cost savings for insurers; and they provide a better experience for patients."

"Mi-eye provides the injured patient with an answer to their injury during their first visit to the orthopedic surgeons office. It will shrink the time from injury to recovery and reduce cost to the healthcare system. This financing will allow Trice to begin marketing mi-eye, pending U.S. FDA clearance. This is a tremendous opportunity to lead Trice’s team, expand the company’s value proposition, and partner once again with Safeguard Scientifics. The technology and the current market create the perfect environment for the launch of this product," O’Donnell added.

Formerly known as Trice Orthopedic, the company landed a $3 million bridge loan led by BioStar late last year.

Filed Under: Diagnostics, Funding Roundup, News Well, Orthopedics Tagged With: BioStar Ventures, Personnel Moves, Safeguard Scientifics, Trice Medical

More recent news

  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment
  • Medtronic unveils “MiniMed” as name for soon-to-be separated Diabetes unit
  • Medtronic issues safety notice for Hugo surgical robot console in Europe

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy